| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥86.4B | ¥82.5B | +4.8% |
| Operating Income | ¥4.8B | ¥5.2B | -9.1% |
| Ordinary Income | ¥6.3B | ¥5.4B | +17.0% |
| Net Income | ¥4.2B | ¥3.3B | +26.9% |
| ROE | 10.8% | 9.1% | - |
FY2025 Q3 results: Revenue 86.4B yen (YoY +4.8%), Operating Income 4.8B yen (YoY -9.1%), Ordinary Income 6.3B yen (YoY +17.0%), Net Income 4.2B yen (YoY +26.9%). The company delivered moderate top-line growth while operating profitability declined, presenting a revenue-up-profit-down pattern at the operating level. However, favorable non-operating income contributions drove significant improvements in ordinary income and net income. Basic EPS increased 36.4% to 168.76 yen, outpacing net income growth due to share count changes. The divergence between operating profit decline and net income growth highlights the impact of non-operating factors on bottom-line performance.
Revenue increased 3.9B yen to 86.4B yen, representing 4.8% YoY growth driven by contributions from both business segments. Nursing Care Equipment segment revenue grew 7.5% to 37.1B yen, while Nursing Care segment revenue increased 2.8% to 49.3B yen. The revenue growth was supported by continued service expansion in both care equipment rental and care service operations.
Operating income declined 0.4B yen to 4.8B yen (YoY -9.1%), with operating margin contracting 0.8pt from 6.3% to 5.5%. This profitability erosion reflects cost structure challenges, as gross profit margin of 15.6% remains below typical industry benchmarks of approximately 20%. Cost of sales increased to 73.0B yen, representing 84.4% of revenue and indicating pricing pressure or input cost inflation. SG&A expenses of 8.7B yen consumed 10.1% of revenue, suggesting limited operating leverage despite revenue growth.
Ordinary income improved significantly by 0.9B yen to 6.3B yen (YoY +17.0%), benefiting from 1.8B yen in non-operating income against 0.3B yen in non-operating expenses. Interest expense remained modest at 0.2B yen, resulting in interest coverage ratio of approximately 20x. The substantial 1.5B yen positive gap between ordinary income and operating income (representing 1.7% of revenue) primarily stems from other non-operating income of 0.1B yen and limited financial charges.
Net income increased 0.9B yen to 4.2B yen (YoY +26.9%), with income tax expense of 2.1B yen representing an effective tax rate of approximately 33%. The 1.5B yen difference between ordinary income (6.3B yen) and net income (4.2B yen) reflects normal tax burden without material extraordinary items. Net profit margin improved 0.9pt to 4.9% despite operating margin compression, demonstrating the offsetting impact of non-operating income.
This represents a revenue-up-profit-mixed pattern, where top-line growth was accompanied by operating profit decline but net income growth, indicating operational efficiency challenges masked by favorable non-operating contributions.
Nursing Care segment represents the core business with 57.0% revenue share at 49.3B yen, growing 2.8% YoY with operating income of 2.3B yen and margin of 4.6%. This segment experienced profitability pressure, as operating income declined from 2.9B yen in the prior year, representing a 22.7% decrease despite revenue growth. The margin contraction suggests cost inflation or competitive pricing pressure in care service operations.
Nursing Care Equipment segment contributed 43.0% of revenue at 37.1B yen, growing 7.5% YoY with operating income of 2.5B yen and margin of 6.7%. This segment demonstrated superior profitability with margin expansion, as operating income increased 8.1% from 2.3B yen in the prior year. The equipment rental business exhibits stronger pricing power and cost control relative to the labor-intensive care service segment.
The 2.1pt margin differential between segments (6.7% for Equipment vs 4.6% for Care) reflects inherent business model differences, with equipment rental generating higher returns on assets while care services face labor cost pressures. The contrasting profit trajectories (Equipment +8.1%, Care -22.7%) indicate segment-specific challenges requiring targeted operational improvements in the core Care business.
[Profitability] ROE 10.8% exceeds the company's sustainable baseline, though profit margin sustainability warrants monitoring given operating margin compression. Operating margin 5.5% declined 0.8pt from prior year 6.3%, while net profit margin 4.9% improved 0.9pt from 4.0%, creating a divergence between operating and net profitability trends. Gross profit margin of 15.6% remains structurally low, limiting operating leverage potential. [Cash Quality] Cash and deposits 19.5B yen provide 3.22x coverage of short-term debt, indicating robust liquidity reserves. Working capital of 15.0B yen supports operational flexibility, though receivables turnover of 72 days suggests collection cycle elongation requiring management attention. [Investment Efficiency] Asset turnover 0.95x reflects capital-intensive business model characteristics. Goodwill increased 163% to 1.5B yen and intangible assets increased 75% to 2.0B yen, signaling recent M&A activity requiring future return validation. Inventory 0.2B yen increased 45% YoY, raising questions about inventory management efficiency despite low absolute levels. [Financial Health] Equity ratio 42.9% reflects moderate financial conservatism. Current ratio 160.0% and quick ratio 159.3% demonstrate strong short-term solvency. Debt-to-equity ratio 0.60x represents conservative leverage utilization, with total interest-bearing debt of 23.4B yen against equity of 38.9B yen. Long-term loans of 17.3B yen comprise 74% of total debt, indicating appropriate maturity structure.
Cash and deposits increased 1.0B yen YoY to 19.5B yen, supported by net income growth of 4.2B yen and favorable working capital dynamics. The cash accumulation despite ongoing business investment suggests positive operational cash generation. Trade receivables increased 0.5B yen to 17.0B yen, with DSO of 72 days indicating extended collection cycles that warrant monitoring for credit risk and working capital efficiency. Trade payables of 2.3B yen represent limited supplier financing utilization relative to receivables, suggesting opportunity for working capital optimization. The balance sheet expansion reflects asset growth from 88.6B yen to 90.6B yen, with property, plant and equipment increasing to 42.6B yen representing 47% of total assets, consistent with facility-intensive care operations. Goodwill and intangible asset increases totaling 1.8B yen signal M&A investment activity. Cash coverage of short-term liabilities stands at 3.22x, providing substantial liquidity cushion. Retained earnings increased 2.6B yen to 28.9B yen, reflecting profit accumulation net of dividend distributions and supporting internal financing capacity.
Ordinary income of 6.3B yen versus operating income of 4.8B yen shows non-operating net contribution of approximately 1.5B yen, representing 23.8% of operating income and 1.7% of revenue. This comprises primarily other non-operating income components, with interest expense of 0.2B yen remaining minimal relative to operating profit. Non-operating income of 1.8B yen against non-operating expenses of 0.3B yen creates a 1.5B yen positive gap that significantly enhances profitability beyond core operations. The reliance on non-operating income to drive bottom-line growth while operating profit declined raises questions about underlying business momentum sustainability. Interest expense represents only 0.2% of revenue, indicating low financial burden. The comprehensive income of 4.2B yen equals net income, with minimal other comprehensive income items (valuation difference on securities of -0.0B yen), suggesting clean earnings without material unrealized gains or losses. The absence of disclosed operating cash flow limits direct verification of earnings quality, though the cash balance increase and modest receivables growth relative to revenue suggest reasonable cash conversion. The effective tax rate of approximately 33% aligns with normal corporate tax expectations without evidence of tax-driven earnings management.
Progress toward full-year guidance shows revenue at 73.7% (86.4B yen actual vs 117.3B yen forecast), operating income at 70.3% (4.8B yen vs 6.8B yen), and ordinary income at 84.9% (6.3B yen vs 7.4B yen) through Q3. With Q3 representing 75% of the fiscal year, revenue progress trails by 1.3pt while operating income trails by 4.7pt, suggesting Q4 acceleration is required to meet operating profit targets. Ordinary income progress exceeds the standard pace by 9.9pt, driven by stronger-than-anticipated non-operating income contributions. The company has not revised full-year guidance this quarter, maintaining revenue growth forecast of 7.0% and operating income growth of 3.7%. The implied Q4 requirements are 30.9B yen revenue (35.7% of annual total) and 2.0B yen operating income (29.4% of annual total), indicating expected fourth-quarter seasonality or project completions. Given Q3's operating margin of 5.5%, achieving the full-year operating income target requires Q4 operating margin improvement to approximately 6.5%, representing a notable sequential improvement from current trends. The forecast assumes no material changes in cost structure or revenue mix per the standard forecast disclaimers.
Annual dividend forecast of 25.00 yen comprises interim dividend of 13.00 yen and year-end dividend of 20.00 yen, with no revision announced this quarter. Based on forecast EPS of 185.71 yen, the payout ratio calculates to 13.5%, representing highly conservative capital allocation. Using actual Q3 annualized EPS of 168.76 yen, the payout ratio would be approximately 14.8%, still indicating substantial profit retention for growth investment or financial flexibility. The dividend policy demonstrates sustainability with strong coverage from both earnings and cash reserves of 19.5B yen. No share buyback activity is disclosed in the current period. The conservative payout ratio of 13.5-14.8% leaves significant room for future dividend growth or supplemental shareholder returns while maintaining reinvestment capacity. Total shareholder return focuses on dividends only given absence of buyback programs, with dividend yield dependent on market price. The retained earnings increase of 2.6B yen to 28.9B yen confirms profit accumulation supporting both dividend capacity and balance sheet strength.
Operating margin compression risk remains elevated, with Q3 operating margin of 5.5% declining 0.8pt YoY while gross margin of 15.6% remains structurally low relative to typical service industry benchmarks. The Nursing Care segment experienced 22.7% operating profit decline despite revenue growth, indicating cost structure misalignment or pricing pressure that could persist. Without margin recovery, full-year operating income targets requiring 6.5% Q4 margin may prove challenging.
Goodwill and intangible asset impairment risk increased materially, with goodwill rising 163% to 1.5B yen and intangible assets increasing 75% to 2.0B yen, together representing 9.0% of total assets. These increases signal recent M&A activity whose returns remain unproven. If acquired businesses underperform, potential impairment charges could materially impact future earnings and equity value, particularly given the concentration relative to quarterly operating income of 4.8B yen.
Working capital efficiency deterioration poses cash flow risk, with receivables DSO extending to 72 days indicating collection cycle lengthening. The 0.5B yen YoY increase in receivables outpaced revenue growth, suggesting customer payment delays or credit quality concerns. Continued DSO extension could strain cash conversion and require additional working capital investment, reducing free cash flow available for dividends or debt reduction despite adequate current liquidity of 19.5B yen cash.
[Industry Position] (Reference - Proprietary Analysis)
The company operates in the healthcare/eldercare services sector, though benchmarked against the IT & Telecom industry median for reference given data availability. Profitability metrics show ROE of 10.8% exceeding the industry median of 8.3% (2025-Q3, n=104), indicating above-average return generation relative to equity base. Operating margin of 5.5% falls below the industry median of 8.2% (IQR: 3.6%-18.0%), positioning the company in the lower quartile for operational efficiency. Net profit margin of 4.9% similarly trails the industry median of 6.0% (IQR: 2.2%-12.7%), reflecting structural profitability challenges in the labor-intensive care services business.
Financial health indicators demonstrate relative strength, with equity ratio of 42.9% below the industry median of 59.2% (IQR: 42.5%-72.7%) but within the interquartile range, suggesting moderate financial conservatism. Current ratio of 160.0% (1.60x) falls below the industry median of 2.15x (IQR: 1.57x-3.62x), though still indicating adequate short-term liquidity. Financial leverage of 2.33x exceeds the industry median of 1.66x (IQR: 1.36-2.32), reflecting higher balance sheet leverage utilization within acceptable bounds.
Growth and efficiency metrics show revenue growth of 4.8% trailing the industry median of 10.4% (IQR: -1.2%-19.6%), positioning the company as a slower-growth operator in a generally expanding sector. Asset turnover of 0.95x exceeds the industry median of 0.67x (IQR: 0.49-0.93), demonstrating superior asset utilization efficiency. Receivables turnover of 72 days compares to industry median of 61 days (IQR: 46-83 days), indicating slightly extended collection cycles but within normal range. The company's relative positioning reflects trade-offs between growth, margins, and asset efficiency characteristic of mature care services operators.
(Industry: IT & Telecom reference (104 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis)
Key Takeaways from Earnings - Structural profitability divergence between operating and net income levels. Operating income declined 9.1% while net income grew 26.9%, driven by 1.5B yen non-operating income contribution representing 23.8% of operating profit. This divergence indicates operational efficiency challenges masked by favorable financial items, raising sustainability questions if non-operating income normalizes. The gross margin of 15.6% and operating margin compression to 5.5% suggest structural cost pressures requiring business model adjustments or pricing improvements to restore operating leverage.
Segment performance bifurcation signals mixed business momentum. Nursing Care Equipment segment delivered 8.1% profit growth with 6.7% margin, while core Nursing Care segment experienced 22.7% profit decline despite revenue growth, with margin of only 4.6%. The 2.1pt margin gap and contrasting profit trajectories indicate the equipment rental business exhibits superior economics, while labor-intensive care services face cost inflation or competitive pressure. This suggests potential strategic emphasis shift toward higher-margin equipment operations or urgent cost restructuring in care services to restore segment profitability balance.
M&A integration and asset quality transition period underway. Goodwill increased 163% to 1.5B yen and intangible assets rose 75% to 2.0B yen, signaling recent acquisitions totaling approximately 1.8B yen in additional intangible assets. Combined with inventory increase of 45% and receivables DSO extension to 72 days, the balance sheet reflects integration phase dynamics. The 13.5% dividend payout ratio and 19.5B yen cash reserve provide financial flexibility for integration execution, though successful return realization remains unproven and subject to future impairment risk if acquired businesses underperform operational expectations.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.